Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001076809-25-000144
Filing Date
2025-12-10
Accepted
2025-12-10 16:36:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7117
  Complete submission text file 0001076809-25-000144.txt   9009
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Filed by) CIK: 0001076809 (see all company filings)

EIN.: 134032491 | State of Incorp.: DE
Type: SCHEDULE 13G

Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88910 | Film No.: 251562437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)